Publications by authors named "Shoko Inatani"

Claim this Profile
I
Introduction of a carboxylic acid group into pyrazolylpyridine derivatives increased selectivity for inhibition of the 20-HETE synthase CYP4A11/4F2.
Madoka Kawamura, Yohei Kobashi, Hiroaki Tanaka, Ayako Bohno-Mikami, Makoto Hamada, Shoko Inatani

Bioorg Med Chem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis.
Takashi Hirata, Hiroki Ohara, Naoki Kojima, Hiroko Koretsune, Yoshitaka Hasegawa, Shoko Inatani

J Pharmacol Exp Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Metabolism and Disposition of TP0473292, a Novel Oral Prodrug of the Potent Metabotropic Glutamate 2/3 Receptor Antagonist TP0178894 for the Treatment of Depression.
Shoko Inatani, Motoki Ochi, Kohnosuke Kinoshita, Jun-Ichi Yamaguchi, Hiromi Endo

Drug Metab Dispos· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.
Madoka Kawamura, Yohei Kobashi, Hiroaki Tanaka, Ayako Bohno-Mikami, Makoto Hamada, Shoko Inatani

J Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of a clinically effective dose of THY1773, a novel V receptor antagonist, based on preclinical data.
Shoko Inatani, Akiko Mizuno-Yasuhira, Makoto Kamiya, Izumi Nishino, Helene D Sabia

Biopharm Drug Dispos· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
Ippei Yoshida, Kaho Arikawa, Yusuke Honma, Shoko Inatani, Mitsukane Yoshinaga

Antimicrob Agents Chemother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis